NVAX - Novavax, Inc.
About Novavax, Inc. (https://www.novavax.com)
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| John Charles Jacobs | President, Chief Executive Officer & Director | 1967 | $1,547,288 USD |
| Mark Casey | Executive Vice President, Chief Legal Officer & Corporate Secretary | 1963 | $984,255 USD |
| Elaine O'Hara | Executive Vice President & Chief Strategy Officer | 1968 | $947,011 USD |
| James Patrick Kelly | Executive Vice President, Chief Financial Officer & Treasurer | 1966 | $884,281 USD |
| Erika S. Trahan | Associate Director of Investor & Public Relations | – | – |
| Ian J. Watkins | Executive Vice President & Chief Human Resources Officer | 1963 | – |
| Luis Sanay | Vice President of Investor Relations | – | – |
| Richard Crowley | Executive Vice President & Chief Operating Officer | 1957 | – |
| Robert Walker | EVice President and Head of Research & Development | – | – |
| Silvia Taylor | Executive Vice President, Chief Corporate Affairs Officer & Head of Novavax Sweden | – | – |
| Troy Morgan | Senior Vice President, Deputy General Counsel & Chief Compliance Officer | 1971 | – |